Institute for Refractive and Ophthalmic Surgery

What Institute for Refractive and Ophthalmic Surgery does

The Institute for Refractive and Ophthalmic Surgery (IROC AG) is a privately held, single-site ophthalmology clinic headquartered at Stockerstrasse 37 in central Zürich, founded in 2002 by Prof. Dr. med. Dr. rer. nat. Theo Seiler, who performed the world's first laser eye surgery in 1985. The clinic delivers a full spectrum of anterior-segment ophthalmic care — refractive laser procedures (LASIK, SMILE, PRK), cataract surgery with premium intraocular lenses, customized corneal crosslinking for keratoconus, macular therapy (Lucentis/Eylea intravitreal injections), glaucoma management, eyelid surgery, and same-day emergency consultations — supported by a precision technology stack comprising the SCHWIND AMARIS 1050RS excimer laser, Ziemer LDV Z8 and Z2 femtosecond lasers, the MS-39 corneal tomograph, Avedro UV irradiation systems, and Brillouin microscopy co-developed with Harvard University. IROC is the sole provider of customized crosslinking in Switzerland and runs the longest cumulative experience worldwide for the technique, in partnership with University Eye Hospital Dresden.

IROC's commercial model is direct-to-consumer with a hybrid of self-pay and insurance-reimbursed revenue streams. Refractive surgery (CHF 3,200 per eye) and premium lens upgrades (CHF 3,650–3,850 per cataract) are largely out-of-pocket; standard cataract surgery and intravitreal injections are covered under TARDOC; and customized crosslinking is set to enter mandatory Swiss insurance coverage starting 2026. Go-to-market is a mix of direct patient acquisition via the iroc.ch website, optician and ophthalmologist referrals (including the Optics Swiss Services network of ~60 optical stores), patient information evenings, and an international training franchise ('Anterior Segment Excellence', launched 2022) that has hosted 200+ visiting ophthalmologists over the past decade. Pricing is transparently published with bundled post-operative care, and multilingual consultation (English, Spanish, Portuguese, Serbian) supports a modest international patient flow alongside the domestic Swiss base.

Name

Institute for Refractive and Ophthalmic Surgery

Legal name

IROC AG - Institut für Refraktive und Ophthalmo-Chirurgie

Website

https://iroc.ch

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

IROC AG is a privately held, single-site ophthalmology clinic in Zürich, Switzerland, delivering refractive laser surgery, cataract surgery, customized corneal crosslinking, and macular, glaucoma, and eyelid care to individual patients, supported by leading laser platforms and academic-grade research collaborations.

Ownership category

akta.pro rank

Product category

Ophthalmology Services

NAICS

Offices of Physicians (62111), Offices of Optometrists (621320)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

akta.pro secondary industries

Ophthalmology Surgery Centers (HLAFAIAF), Optometry Clinics (Primary Eye Care) (HLAKAKAB)

Keywords

• Refractive eye surgery
• Cataract surgery services
• Ophthalmology clinic
• Keratoconus crosslinking
• Laser vision correction

Headquarters

HQ city

Zurich

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Ophthalmic Surgical Procedures: Revenue generated from surgical procedures including eye laser surgery (LASIK, SMILE, PRK), cataract surgery, keratoconus crosslinking, and other ophthalmic procedures. Pricing follows TARDOC-compliant invoices with transparent flat-rate pricing.
2. Premium Lens Upgrades: Additional revenue from premium intraocular lenses (multifocal, toric, EDOF, monofocal+) and femtosecond laser usage during cataract surgery, which are not covered by standard health insurance.
3. Diagnostic Examinations: Pre-operative examinations and measurements following TARDOC tariff, valid for 6 months. Includes thorough assessment of patient needs, anatomical and physiological measurements.
4. Intravitreal Injections: Lucentis and Eylea injections for macular degeneration covered by Swiss health insurance in most cases.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

The Institute for Refractive and Ophthalmic Surgery (IROC) is a Zurich-based eye clinic that provides surgical and medical ophthalmology services, including refractive laser eye surgery (LASIK, SMILE, PRK), cataract surgery with premium intraocular lenses, customized corneal crosslinking for keratoconus, macular therapy (intravitreal injections), glaucoma treatment, eyelid surgery, emergency consultations, and contact lens fitting. The clinic combines patient care with research and training, performing over 4,000 laser eye surgeries annually and serving both domestic Swiss patients and international visitors.

Product overview

IROC (Institut für Refraktive und Ophthalmo-Chirurgie) is an eye clinic offering a comprehensive range of ophthalmological treatments and services. The core offerings include refractive laser eye surgery (LASIK, SMILE, PRK), cataract surgery with premium intraocular lenses (toric, multifocal, EDOF), keratoconus treatment via customized crosslinking, macular therapy for AMD, glaucoma treatment, and eyelid surgery. The clinic operates specialized equipment including SCHWIND AMARIS 1050RS excimer laser, ZIEMER femtosecond lasers, MS-39 corneal tomograph, and Brillouin microscopy for advanced diagnostics. Additional services include emergency consultations, contact lens fitting, and professional training programs for ophthalmologists.

Differentiator

Problem solved

Functional benefit

Products and services

• Eye Laser Treatment (LASIK / SMILE / PRK)

Quantifiable outcome

• Cataract surgery complication rates minimized through detailed pre-examination, surgeon experience, and femtosecond laser
• +3 more outcomes

Named customers6 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Schwind Eye Tech SolutionscoreTechnology or Integration · 1 January 2016IROC has been working with Schwind company's AMARIS 1050RS excimer laser since spring 2016. Prof. Seiler's experience and achievements with the new Schwind laser have been featured in Schwind newsletters.
• Ziemer GroupcoreTechnology or IntegrationIROC uses Ziemer LDV Z8 and LDV Z2 femtosecond lasers. Close collaboration ensures access to most recent laser technologies. Frau Etter from Ziemer has participated in training visits.
• AvedrocoreTechnology or IntegrationIROC uses Avedro's UV irradiation systems for crosslinking procedures, enabling advanced keratoconus treatment.
• Harvard UniversitycoreStrategic or Co-development PartnerIROC developed Brillouin microscopy in cooperation with Harvard University - an innovative diagnostic procedure for superior keratoconus diagnosis.
• University Eye Hospital DresdencoreStrategic or Co-development PartnerTogether with University Eye Hospital Dresden, IROC has the longest experience worldwide in customized crosslinking. Joint research has advanced the method.
• University of BernminorStrategic or Co-development PartnerPD Dr. Theo G. Seiler appointed professor at University of Bern as of March 2026, strengthening academic ties.
• Optics Swiss Services (OSS)minorGTM or Marketing PartnerIROC experts speak at OSS continuing education events. OSS is a purchasing and networking organization with approximately 60 specialty optical stores in Switzerland as members.
• Kamran M. Riaz (Dean McGee Eye Institute, University of Oklahoma)minorStrategic or Co-development PartnerCo-authored international study on secondary lens implants with Prof. Kamran M. Riaz from University of Oklahoma.
• Swiss Ophthalmological Society (SOG) - Refractive Surgery CommissioncoreStrategic or Co-development PartnerPD Dr. Theo Seiler founded and was elected president of the first Refractive Surgery Commission in Switzerland, based on the German KRC model. Commission develops evidence-based treatment recommendations.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Care Vision: Germany-based refractive surgery clinic network performing LASIK, SMILE, PRK and ICL. Comparable in volume-per-site, surgeon-led premium positioning and DACH patient-recruitment tactics to IROC.
• Pallas Kliniken: Swiss ophthalmology and aesthetic clinic chain operating multiple sites in German-speaking Switzerland. Prof. Maya Müller was Medical Director at Pallas Kliniken from 2012-2019 before joining IROC, indicating direct overlap in refractive/cataract clinical model and patient demographic.
• EuroEyes: German-listed premium refractive surgery chain (LASIK, SMILE, ICL, cataract) expanding across DACH and China. Closest publicly traded comparable for IROC's elective refractive + premium IOL model, with similar technology stack (Zeiss/Schwind lasers).
• Augenklinik Dardenne: Premium German eye surgery hospital combining refractive surgery, cataract with premium IOLs and corneal procedures. Closely aligned to IROC's full-service ophthalmic-surgery mix and surgeon-led private clinic structure.
• Smile Eyes: German refractive clinic chain focused on SMILE/LASIK/IOL cataract. Provides DACH direct competitor on premium refractive patient acquisition, surgeon training model, and Schwind/Ziemer-type equipment stack.
• EyeLaser Center: Austrian/Swiss premium refractive clinic chain offering LASIK, SMILE, ICL and cataract with femto. Comparable in clinical positioning (premium, fellowship-trained surgeons) and pricing tier to IROC's Zurich outpatient model.

Broad incumbents

• Optical Express: UK-headquartered, large-scale refractive and private ophthalmology chain with high patient throughput. Distinct from IROC via scale and high-street retail model but overlaps on core refractive-laser and premium IOL offerings.

Others

• STAAR Surgical: US-listed maker of Implantable Collamer Lenses (ICL/Visian) used in IROC's phakic lens implantation service (CHF 3,450 procedure). Adjacent supplier; an emerging phakic-IOL player whose pipeline could substitute or extend IROC's high-myopia offering.
• Schwind Eye Tech Solutions: German manufacturer of excimer laser platforms (incl. AMARIS 1050RS) used by IROC. Strategic technology partner since 2016 and an adjacent ecosystem vendor shaping the standard of care IROC's refractive volumes depend on.
• Ziemer Group: Swiss-headquartered manufacturer of femtosecond laser systems (LDV Z8, LDV Z2) deployed at IROC. Adjacent technology partner whose product roadmap directly determines IROC's cataract and refractive surgical capability.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute for Refractive and Ophthalmic Surgery